Drugs / Conjugated Linolenic Acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02433977 | Sep 2015 → Nov 2019 | asthma | Gladwin, Mark, MD | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Conjugated Linolenic Acid | “Conjugated Linolenic Acid + NOx” NCT02433977 ↗ |
| Known as | conjugated linolenic acid (CLA) | “conjugated linolenic acid (CLA)” NCT02433977 ↗ |
| Route | Oral | “capsules for daily oral administration” NCT02433977 ↗ |